A 9-wk docosahexaenoic acid-enriched supplementation improves endurance exercise capacity and skeletal muscle mitochondrial function in adult rats

Am J Physiol Endocrinol Metab. 2016 Feb 1;310(3):E213-24. doi: 10.1152/ajpendo.00468.2014. Epub 2015 Dec 8.

Abstract

Decline in skeletal muscle mass and function starts during adulthood. Among the causes, modifications of the mitochondrial function could be of major importance. Polyunsaturated fatty (ω-3) acids have been shown to play a role in intracellular functions. We hypothesize that docosahexaenoic acid (DHA) supplementation could improve muscle mitochondrial function that could contribute to limit the early consequences of aging on adult muscle. Twelve-month-old male Wistar rats were fed a low-polyunsaturated fat diet and were given DHA (DHA group) or placebo (control group) for 9 wk. Rats from the DHA group showed a higher endurance capacity (+56%, P < 0.05) compared with control animals. Permeabilized myofibers from soleus muscle showed higher O2 consumptions (P < 0.05) in the DHA group compared with the control group, with glutamate-malate as substrates, both in basal conditions (i.e., state 2) and under maximal conditions (i.e., state 3, using ADP), along with a higher apparent Km for ADP (P < 0.05). Calcium retention capacity of isolated mitochondria was lower in DHA group compared with the control group (P < 0.05). Phospho-AMPK/AMPK ratio and PPARδ mRNA content were higher in the DHA group compared with the control group (P < 0.05). Results showed that DHA enhanced endurance capacity in adult animals, a beneficial effect potentially resulting from improvement in mitochondrial function, as suggested by our results on permeabilized fibers. DHA supplementation could be of potential interest for the muscle function in adults and for fighting the decline in exercise tolerance with age that could imply energy-sensing pathway, as suggested by changes in phospho-AMPK/AMPK ratio.

Keywords: isolated mitochondria; muscle bioenergetics; permeabilized myofibers; polyunsaturated fatty acids.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Hydroxyacyl CoA Dehydrogenases / drug effects
  • 3-Hydroxyacyl CoA Dehydrogenases / metabolism
  • Animals
  • Blotting, Western
  • Calcium / metabolism
  • Calorimetry, Indirect
  • Cell Membrane / drug effects*
  • Cell Membrane / metabolism
  • Cholesterol / metabolism
  • Citrate (si)-Synthase / drug effects
  • Citrate (si)-Synthase / metabolism
  • Dietary Supplements*
  • Docosahexaenoic Acids / pharmacology*
  • Electron Transport / drug effects
  • Exercise Tolerance / drug effects*
  • Hydrogen Peroxide / metabolism
  • Male
  • Mitochondria, Muscle / drug effects*
  • Mitochondria, Muscle / metabolism
  • Muscle Fibers, Skeletal / drug effects
  • Muscle Fibers, Skeletal / metabolism
  • Muscle, Skeletal / drug effects*
  • Muscle, Skeletal / metabolism
  • Oxygen Consumption / drug effects
  • Phospholipids / metabolism
  • Physical Conditioning, Animal
  • Physical Endurance / drug effects*
  • RNA, Messenger / drug effects*
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar
  • Real-Time Polymerase Chain Reaction
  • Triglycerides / metabolism

Substances

  • Phospholipids
  • RNA, Messenger
  • Triglycerides
  • Docosahexaenoic Acids
  • Cholesterol
  • Hydrogen Peroxide
  • 3-Hydroxyacyl CoA Dehydrogenases
  • Citrate (si)-Synthase
  • Calcium